Purines and Myocardial Protection: Developments in Cardiovascular Medicine, cartea 181
Editat de Anwar-Saad A. Abd-Elfattah, Andrew S. Wechsleren Limba Engleză Hardback – 31 ian 1996
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 2039.26 lei 6-8 săpt. | |
Springer Us – 27 sep 2011 | 2039.26 lei 6-8 săpt. | |
Hardback (1) | 2046.31 lei 6-8 săpt. | |
Springer Us – 31 ian 1996 | 2046.31 lei 6-8 săpt. |
Din seria Developments in Cardiovascular Medicine
- 5% Preț: 1484.50 lei
- 5% Preț: 375.17 lei
- 5% Preț: 354.10 lei
- 5% Preț: 1365.22 lei
- 5% Preț: 362.28 lei
- 5% Preț: 1056.66 lei
- 5% Preț: 1383.84 lei
- 5% Preț: 362.63 lei
- 5% Preț: 354.53 lei
- 5% Preț: 365.97 lei
- 5% Preț: 2037.17 lei
- 5% Preț: 353.48 lei
- 5% Preț: 352.79 lei
- 5% Preț: 357.17 lei
- 5% Preț: 357.01 lei
- 5% Preț: 753.57 lei
- 5% Preț: 686.22 lei
- 5% Preț: 1056.66 lei
- 5% Preț: 361.39 lei
- 5% Preț: 359.45 lei
- 5% Preț: 696.56 lei
- 5% Preț: 1062.27 lei
- 5% Preț: 2036.81 lei
- 5% Preț: 689.01 lei
- 5% Preț: 358.05 lei
- 5% Preț: 695.02 lei
- 5% Preț: 635.16 lei
- 5% Preț: 361.23 lei
- 5% Preț: 1369.25 lei
- 5% Preț: 688.32 lei
- 5% Preț: 760.80 lei
- 5% Preț: 693.42 lei
- 5% Preț: 3064.43 lei
- 5% Preț: 1364.49 lei
- 5% Preț: 754.97 lei
- 5% Preț: 687.61 lei
- 5% Preț: 356.81 lei
- 5% Preț: 362.08 lei
- 5% Preț: 635.88 lei
- 5% Preț: 354.53 lei
Preț: 2046.31 lei
Preț vechi: 2154.01 lei
-5% Nou
Puncte Express: 3069
Preț estimativ în valută:
391.61€ • 414.15$ • 326.66£
391.61€ • 414.15$ • 326.66£
Carte tipărită la comandă
Livrare economică 30 decembrie 24 - 13 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780792338314
ISBN-10: 0792338316
Pagini: 564
Ilustrații: XXIV, 564 p.
Dimensiuni: 155 x 235 x 32 mm
Greutate: 1 kg
Ediția:1996
Editura: Springer Us
Colecția Springer
Seria Developments in Cardiovascular Medicine
Locul publicării:New York, NY, United States
ISBN-10: 0792338316
Pagini: 564
Ilustrații: XXIV, 564 p.
Dimensiuni: 155 x 235 x 32 mm
Greutate: 1 kg
Ediția:1996
Editura: Springer Us
Colecția Springer
Seria Developments in Cardiovascular Medicine
Locul publicării:New York, NY, United States
Public țintă
ResearchCuprins
I: Purine Metabolism in the Heart.- 1. Physiologic and Pathophysiologic Significance of Purine Metabolism in the Heart.- 2. Purine Metabolism in the Ischemic Canine and Human Immature Myocardium Deficient of 5?-Nucleotidase.- 3. Cardiac adenosine Metabolism: Physiological Implications.- 4. Purines Metabolism in Human Cardiomyocytes and Endothelium-Implications for Protection of the Heart during Cardiac Surgery.- 5. Assessment of Interstitial Fluid Adenosine: Implications for Exogenous or Endogenous and Endogenous Adenosine-Mediated Cardioprotection.- 6. Adenosine and Coronary Vascular Pharmacology.- 7. Alternations in Energy Substrate Metabolism during Oxidative Stress.- II: Myocardial Protection with Purines.- 8. Purines and Myocardial Protection: An Overview.- A. Myocardial Protection with Endogenous Purines.- 9. Nucleoside Transport Protein: Properties and Regulation.- 10. Role of Nucleoside Transport in Myocardial Injury and Protection: Separation Between Ischemic and Reperfusion Injury using a Selective Nucleoside Transport Blocker, p-Nitrobenzylthoinosine NBMPR.- 11. Myocardial Protection using Nucleoside Transport Inhibitors.- 12. Selective Blockade of Nucleoside Transport by NBMPR Attenuates Reperfusion-Mediated Ventricular Arrhythmias.- 13. Nucleoside Transport in the Human Myocardium.- 14. Selective Nucleoside Transport Blocker NBMPR Attenuates Myocardial Stunning in a Rabbit Model Deficient of Xanthine Oxidase.- 15. Amplification of Endogenous adenosine by “Adenosine Regulating Agents” as a Therapeutic Approach to the Treatment of Cardiac Ischemic Syndromes.- B. Myocardial Protection with Exongenous Purines.- 16. Organ Protection with ATP-Magnesium Chloride.- 17. Adenosine and Adenosine Receptor Protection of the Ischemic Heart.- 18. Effect of Adenosineon Myocardial stunning.- 19. Cardioprotection from Ischemic-Reperfusion Injury by Adenosine.- 20. Cardioprotection with Adenosine, inosine and Hypoxanthine.- 21. Adenosine and Adrenergic Mediated Effects in the Heart.- 22. Effects of Adenosine on Ventricular Tachycardia.- 23. Purines and Ventricular Arrhythmias.- 24. Adenosine and the Polymorphonuclear Leukocyte Function Mechanisms and Production.- 25. Purines and Regulation of Platelet Activation.- III: Purines and Myocardial Preconditioning.- 26. Myocardial Preconditioning: From a Model to a Phenomenon.- 27. ATP Metabolism and Ischemic Preconditioning.- 28. Do Adenosine A3 Receptors Cause Preconditioning?.- 29. KATP Channels and Adenosine Receptors and Ischemic Preconditioning.- 30. Role of Activation of Ecto-5?-Nucleotidase for Cardioprotection in Ischemic and Reperfusion Injury: Role of Purine and Adenosine Metabolism.- 31. Ischemic Preconditions in a Model of Isolated Cardiomyocytes.- 32. Integration of Adenosine and Noradrenergic Pathways in Cardiac Preconditioning.- 33. Myocardial Stunning and Preconditioning during Non-cardioplegic Warm Intermittent Aortic Crossclamping.- IV: Purines and Intracellular Calcium.- 34. Energy and Cation Control in the Reoxygenated Myocardial Cell.- 35. Cystolic Calcium Transport during Myocardial Protection.- 36. Future Therapueitc Use of Purines in Myocardial Protection.